Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
outpatient with HCV not receiving or planning treatment but is receiving standard of care monitoring every 3 months, abstinent or drinking
Outpatient with HCV who is not receiving or planning treatment but is receiving standard of care monitoring every 3 months and is either abstinent from alcohol or drinking only moderately
Treated within the past 6 months
History (hx) of other liver disease
Alcohol use greater than 30 g/day or history of binge drinking in the last year
RNA Virus Infections Ethanol
Digestive System Diseases
Hepatitis, Viral, Human
Anti-Infective Agents, Local
Central Nervous System Depressants
Physiological Effects of Drugs